Assessment of molecular events in squamous and non-squamous cell lung carcinoma

Lung Cancer

Volumn 54, Issue 3, 2006, Pages 293-301

  Yakut, Tahsin ^a   Schulten, Hans Jürgen ^b   Demir, Adalet ^c   Frank, Derk ^d   Danner, Bernd ^b   Egeli, Ünal ^a   Gebitekin, Cengiz ^a   Kahler, Elke ^b   Gunawan, Bastian ^b   Ürer, Nur ^c   Öztürk, Hülya ^a   Füzesi, László ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Yedikule Teaching Hospital   (Turkey)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Comparative genomic hybridization; Epidermal growth factor receptor; Non small cell lung carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHROMOSOME 12P; CHROMOSOME 14Q; CHROMOSOME 1Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOMIC INSTABILITY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33750352066     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.08.011     Document Type: Article

References (38)

1. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon
2. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57 (1997) 2331-2335
3. Michelland S., Gazzeri S., Brambilla E., and Robert-Nicoud M. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet Cytogenet 114 (1999) 22-30
4. Luk C., Tsao M.S., Bayani J., Shepherd F., and Squire J.A. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridisation. Cancer Genet Cytogenet 125 (2001) 87-99
5. Balsara B.R., and Testa J.R. Chromosomal imbalances in human lung cancer. Oncogene 21 (2002) 6877-6883
6. Testa J.R., Liu Z., Feder M., Bell D.W., Balsara B., Cheng J.Q., et al. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 95 (1997) 20-32
7. Daigo Y., Nishiwaki T., Kawasoe T., Tamari M., Tsuchiya E., and Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 59 (1999) 1966-1972
8. Massion P.P., Taflan P.M., Jamshedur Rahman S.M., Yildiz P., Shyr Y., Edgerton M.E., et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63 (2003) 7113-7121
9. Suzuki M., Shigematsu H., Hiroshima K., Iizasa T., Nakatani Y., Minna J.D., et al. Epidermal growth factor receptor expression status in lung cancer correlates with its mutation. Hum Pathol 36 (2005) 1127-1134
10. Nakamura H., Kawasaki N., Taguchi M., and Kabasawa K. Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis. Thorax 61 (2006) 140-145
11. Hirsch F.R., and Bunn Jr. P.A. Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?. J Clin Oncol 23 (2005) 9044-9047
12. Fidaner C., Eser S.Y., and Parkin D.M. Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer 37 (2001) 83-92
13. Goksel T., and Akkoclu A. Turkish Thoracic Society, Lung and Pleural Malignancies Study Group. Pattern of lung cancer in Turkey, 1994-1998. Respiration 69 (2002) 207-210
14. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York
15. Storkel S., Reichert T., Reiffen K.A., and Wagner W. EGFR and PCNA expression in oral squamous cell carcinomas-a valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol B 29 (1993) 273-277
16. Gunawan B., Schulten H.J., von Heydebreck A., Schmidt B., Enders C., Hoer J., et al. Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol 202 (2004) 421-429
17. Baudis M. An online database and bioinformatics toolbox to support data mining in cancer cytogenetics. Biotechniques 40 (2006) 272-296
18. Tonon G., Wong K.K., Maulik G., Brennan C., Feng B., Zhang Y., et al. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102 (2005) 9625-9630
19. Pei J., Balsara B.R., Li W., Litwin S., Gabrielson E., Feder M., et al. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 31 (2001) 282-287
20. Chujo M., Noguchi T., Miura T., Arinaga M., Uchida Y., and Tagawa Y. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 38 (2002) 23-29
21. Sy S.M., Wong N., Lee T.W., Tse G., Mok T.S., Fan B., et al. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer 40 (2004) 1082-1094
22. Garnis C., Lockwood W.W., Vucic E., Ge Y., Girard L., Minna J.D., et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 118 (2006) 1556-1564
23. Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., and Inazawa J. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 9 (2003) 4705-4713
24. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
25. Balsara B.R., Sonoda G., du Manoir S., Siegfried J.M., Gabrielson E., and Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57 (1997) 2116-2120
26. Bjorkqvist A.M., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., Tammilehto L., Mattson K., et al. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer 22 (1998) 79-82
27. Goeze A., Schluns K., Wolf G., Thasler Z., Petersen S., and Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196 (2002) 8-16
28. Tai A.L., Yan W.S., Fang Y., Xie D., Sham J.S., and Guan X.Y. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Cancer 100 (2004) 1918-1927
29. Petersen S., Aninat-Meyer M., Schluns K., Gellert K., Dietel M., and Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 82 (2000) 65-73
30. Manenti G., De Gregorio L., Pilotti S., Falvella F.S., Incarbone M., Ravagnani F., et al. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis 18 (1997) 1917-1920
31. De Gregorio L., Manenti G., Incarbone M., Pilotti S., Pastorino U., Pierotti M.A., et al. Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma. Int J Cancer 79 (1998) 269-272
32. Hermsen M., Guervos M.A., Meijer G., Baak J., van Diest P., Marcos C.A., et al. New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridisation. J Pathol 194 (2001) 177-182
33. Yamayoshi T., Nagayasu T., Matsumoto K., Abo T., Hishikawa Y., and Koji T. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J Pathol 204 (2004) 110-118
34. Hirsch F.R., Varella-Garcia M., Bunn Jr. P.A., Di Maria M.V., Veve R., Bremmes R.M., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21 (2003) 3798-3807
35. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
36. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
37. Hibi K., Trink B., Patturajan M., Westra W.H., Caballero O.L., Hill D.E., et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97 (2000) 5462-5467
38. Nishi H., Senoo M., Nishi K.H., Murphy B., Rikiyama T., Matsumura Y., et al. p53 homologue p63 represses epidermal growth factor receptor expression. J Biol Chem 276 (2001) 41717-41724